Cardiovascular disease

Kim and Bethan Nanion
#ApconiX #Cardiovascular disease #Drug discovery #Podcast #Screening

The benefits of early ion channel screening

The latest sponsored DDW Sitting Down With podcast features Dr Michael Morton, Director and Co-founder, ApconiX, and Dr Kimberly Rockley of ApconiX who discuss the benefits of early ion channel screening. The podcast covers the hERG ion channel and its importance in cardiac safety screening in drug discovery. … Read More

#News

Covid-19 vaccination
#Cardiovascular disease #Covid-19 #Covid-19 vaccine #Immunology / Virology & Vaccines

Covid-19 vaccination reduces risk of cardiac events

Researchers have revealed that vaccination against Covid-19 is associated with fewer heart attacks, strokes, and other cardiovascular issues among people who were infected with SARS-CoV-2.  The conclusions are based on analysis of the most extensive datasets in the United States by a team from the Icahn School… Read More

#News #Trending News

MHRA
#AstraZeneca #Cardiovascular disease #Heart disease #MHRA

UK licence extension approved for AstraZeneca’s dapagliflozin

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted a licence extension for dapagliflozin for the treatment of symptomatic chronic heart failure (HF).  The drug is approved in patients with HF and a left ventricular ejection fraction (LVEF) >40%, including HF with mildly reduced ejection… Read More

#News #Regulatory

Patient using blood pressure monitor
#Cardiovascular disease #European Association for the Study of Diabetes #Type 2 diabetes

Analysis confirms cardiovascular benefits Ozempic

New trial data has shown consistent cardiovascular benefits from Novo Nordisk’s semaglutide in adults with type 2 diabetes, regardless of baseline blood sugar or kidney function. The results show that treatment with Ozempic (once-weekly semaglutide) or Rybelsus (oral semaglutide) demonstrated consistent reductions in major adverse cardiovascular events (MACE) compared with… Read More

#News

Diabetes patient injecting insulin
#Autoimmune disease #Biomedical research #Cardiovascular disease #Diabetes #Statins #Type 2 diabetes

Study: autoimmune disorders increase cardiovascular risk

Individuals with an autoimmune disorder have a substantially higher risk of developing cardiovascular disease, a large epidemiological study has revealed.  The research – led by KU Leuven in collaboration with colleagues in the UK, including the University of Glasgow, and published in The Lancet – shows for the first… Read More

#News

#Cardiovascular disease #Collaboration #Drug discovery

Novartis collaboration has potential to improve heart health in UK 

Novartis and NHS England are to pioneer a population health management approach to address elevated LDL-C in patients with Atherosclerotic Cardiovascular Disease (ASCVD) across England.  The collaboration received positive final recommendation from the National Institute for Health and Care Excellence (NICE) for use of inclisiran in primary care for the treatment of adult patients within… Read More

#Business & Investment #News

#Biotherapeutics #Cardiovascular disease #Clinical trials #mRNA #Therapeutics

Positive data from study of siRNA in iron-loading anaemia conditions

Silence Therapeutics and Nasdaq have announced positive topline data from the GEMINI Phase I study of its wholly owned product candidate, SLN124, in healthy volunteers. SLN124, an siRNA which targets TMPRSS6, is in development for the treatment of iron-loading anaemia conditions, thalassemia and myelodysplastic syndrome (MDS). The GEMINI Phase I,… Read More

#News